In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
Covid-19 vaccines, credited with saving millions of lives during the pandemic, set off a powerful alarm that rallies the human immune system against cancer and nearly doubles the median survival ...
WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...
Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.
Different variants of a gene, known as isoforms, can be transcribed and translated at varying levels within a cell or tissue. These isoforms are commonly a result of alternative splicing, which ...
Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...
August is going out like a lamb after some scorching heat waves earlier this summer. The summer's unofficial end is looking cool and dry as Labor Day nears, according to the National Weather Service.
Health officials during the first term said mRNA shots are safe and effective. When the Pfizer-BioNTech COVID-19 vaccine was authorized for emergency use by the Food and Drug Administration (FDA) in ...
Jay Bhattacharya is director of the National Institutes of Health. The U.S. Department of Health and Human Services’ decision to wind down its mRNA vaccine development activities marks a necessary ...
Founder of the Medulloblastoma Initiative, Fernando Goldsztein, discusses the new MBI-funded research on experimental mRNA vaccines to treat cancer. Donald Trump's executive order changing 401(k)s: ...
Many public health experts and scientists say they are stunned by Health Secretary Robert F. Kennedy Jr’s decision to cancel nearly half a billion dollars in federal funding for future vaccine ...